Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-07T20:03:03.430Z Has data issue: false hasContentIssue false
  • English
  • Français

Route of administration for antibiotics with high oral bioavailability

Published online by Cambridge University Press:  27 December 2018

Michael J. Smith Open the ORCID record for Michael J. Smith [Opens in a new window] ,
Cary Thurm ,
Samir S. Shah ,
Sameer J. Patel ,
Matthew P. Kronman ,
Jeffrey S. Gerber ,
Joshua D. Courter ,
Brian R. Lee ,
Jason G. Newland  and
Adam L. Hersh
Michael J. Smith*
Affiliation:
Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina
Cary Thurm
Affiliation:
Children’s Hospital Association, Overland Park, Kansas
Samir S. Shah
Affiliation:
Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio
Sameer J. Patel
Affiliation:
Division of Pediatric Infectious Disease, Ann & Robert H. Lurie Children’s Hospital, Chicago, Illinois
Matthew P. Kronman
Affiliation:
Division of Infectious Diseases, Seattle Children’s Hospital, University of Washington School of Medicine, Seattle, Washington
Jeffrey S. Gerber
Affiliation:
Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Joshua D. Courter
Affiliation:
Division of Pharmacy, Cincinnati Children’s Hospital Medical, Cincinnati, Ohio
Brian R. Lee
Affiliation:
Division of Infectious Diseases, Children’s Mercy Hospital-Kansas City, Kansas City, Missouri
Jason G. Newland
Affiliation:
Division of Pediatric Infectious Diseases, Washington University School of Medicine, St Louis, Missouri
Adam L. Hersh
Affiliation:
Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City, Utah
*
Author for correspondence: Michael J. Smith, MD, MSCE, Pediatric Infectious Diseases, Box 3499 Duke University Medical Center, Durham, North Carolina, 27710. E-mail: michael.j.smith@duke.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Brief
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 2 , February 2019 , pp. 248 - 249
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: These data were presented in part at IDWeek on October 6, 2017, in San Diego, California.

Cite this article: Smith MJ, et al. (2019). Route of administration for antibiotics with high oral bioavailability. Infection Control & Hospital Epidemiology 2019, 40, 248–249. doi: 10.1017/ice.2018.329

References

1. Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:E51–E77.Google Scholar
2. Pediatric Health Information System (PHIS). Children’s Hospital Association website. https://www.childrenshospitals.org/programs-and-services/data-analytics-and-research/pediatric-analytic-solutions/pediatric-health-information-system. Accessed March 16, 2018.Google Scholar
3. Goldman, JL, Richardson, T, Newland, JG, et al. Outpatient parenteral antimicrobial therapy in pediatric medicaid enrollees. J Pediatr Infect Dis Soc 2017;6:65–71.Google Scholar
4. Zaoutis, T, Localio, AR, Leckerman, K, Saddlemire, S, Bertoch, D, Keren, R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics 2009;123:636–642.Google Scholar
5. Keren, R, Shah, SS, Srivastava, R, et al. Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children. JAMA Pediatrics 2015;169:120–128.Google Scholar
6. Shah, SS, Srivastava, R, Wu, S, et al. Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia. Pediatrics 2016;138:9.Google Scholar
7. Broom, J, Broom, A, Adams, K, Plage, S. What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors’ accounts of what influences their clinical practice. J Antimicrob Chemother 2016;71:2295–2299.Google Scholar
8. Jones, M, Huttner, B, Madaras-Kelly, K, et al. Parenteral to oral conversion of fluoroquinolones: low-hanging fruit for antimicrobial stewardship programs? Infect Control Hosp Epidemiol 2012;33:362–367.Google Scholar
9. McPherson, C, Lee, BR, Terrill, C, et al. Characteristics of pediatric antimicrobial stewardship programs: current status of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) collaborative. Antibiotics (Basel) 2018;7.Google Scholar